Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23414)

Formulation Name
Cysteamine Bitartrate eq 50mg base capsule
Company
Mylan Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Cysteamine DMSYFM8 Nephropathic cystinosis 5C60 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Ammonium hydroxide E00687 Not Available Alkalizing agent
Carmellose sodium E00625 Not Available Disintegrant
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Ferric oxide black E00522 16211978 Colorant
Gelatin E00630 Not Available Other agent
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Magnesium stearate E00208 11177 lubricant
Pregelatinized starch E00674 Not Available Binding agent; Diluent; Disintegrant
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent